Prometheus the Latest Buy for Nestle's Health Sciences Unit
By Jennifer Boggs
Thursday, May 26, 2011
San Diego-based Prometheus Laboratories Inc., a specialty pharma and diagnostics company that has spent nearly four years in the initial public offering (IPO) queue, will become the latest acquisition of Nestle Health Sciences SA, as the Swiss firm expands its efforts in the new area of science-based nutrition.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.